| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Institute of Signaling, Developmental Biology and Cancer Research, Centre National de la Recherche Scientifique, UMR 6543, Université de Nice, Centre Antoine Lacassagne, Nice, France
Requests for reprints: Nathalie M. Mazure, Institute of Signaling, Developmental Biology and Cancer Research, Centre National de la Recherche Scientifique, UMR 6543, 33 Avenue de Valombrose, 06189 Nice, France. Phone: 33-4-92-03-12-22; Fax: 33-4-92-03-12-25; E-mail: mazure{at}unice.fr or Jacques.Pouyssegur{at}unice.fr.
The function of the hypoxia-inducible factor-1 (HIF-1), the key transcription factor involved in cellular adaptation to hypoxia, is restricted to low oxygen tension (pO2). As such, this transcription factor is central in modulating the tumor microenvironment, sensing nutrient availability, and controlling anaerobic glycolysis, intracellular pH, and cell survival. Degradation and inhibition of the limiting HIF-1
subunit are intimately connected in normoxia. Hydroxylation of two proline residues by prolyl hydroxylase domain (PHD) 2 protein earmarks the protein for degradation, whereas hydroxylation of an asparagine residue by factor-inhibiting HIF-1 (FIH-1 or FIH) reduces its transcriptional activity. Indeed, silencing of either PHD2 or FIH in normoxia partially induced hypoxic genes, whereas combined PHD2/FIH silencing generated a full hypoxic gene response. Given the fact that HIF-1
possesses two transcriptional activation domains [TAD; NH2-terminal (N-TAD) and COOH-terminal (C-TAD)], we hypothesized on a possible bifunctional activity of HIF-1
that could be discriminated by FIH, an inhibitor of the C-TAD. In human cell lines engineered to overexpress or silence FIH in response to tetracycline, we show by quantitative reverse transcription-PCR that a set of hypoxic genes (ca9, phd3, pgk1, and bnip3) respond differently toward FIH expression. This finding, extended to 26 hypoxia-induced genes, indicates differential gene expression by the N-TAD and C-TAD in response to the hypoxic gradient. We propose that the oxygen-sensitive attenuator FIH, together with two distinct TADs, is central in setting the gene expression repertoire dictated by the cell pO2. (Cancer Res 2006; 66(7): 3688-98)
This article has been cited by other articles:
![]() |
W. A. Van Voorhies Metabolic function in Drosophila melanogaster in response to hypoxia and pure oxygen J. Exp. Biol., October 1, 2009; 212(19): 3132 - 3141. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Lee, J.-H. Lim, Y.-S. Chun, H.-E. Moon, M. K. Lee, L.E. Huang, and J.-W. Park Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1{alpha} Carcinogenesis, October 1, 2009; 30(10): 1768 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gunaratnam and J. V. Bonventre HIF in Kidney Disease and Development J. Am. Soc. Nephrol., September 1, 2009; 20(9): 1877 - 1887. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Partch, P. B. Card, C. A. Amezcua, and K. H. Gardner Molecular Basis of Coiled Coil Coactivator Recruitment by the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) J. Biol. Chem., May 29, 2009; 284(22): 15184 - 15192. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bellot, R. Garcia-Medina, P. Gounon, J. Chiche, D. Roux, J. Pouyssegur, and N. M. Mazure Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains Mol. Cell. Biol., May 15, 2009; 29(10): 2570 - 2581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Brahimi-Horn and J. Pouyssegur HIF at a glance J. Cell Sci., April 15, 2009; 122(8): 1055 - 1057. [Full Text] [PDF] |
||||
![]() |
M. Z. Noman, S. Buart, J. Van Pelt, C. Richon, M. Hasmim, N. Leleu, W. M. Suchorska, A. Jalil, Y. Lecluse, F. El Hage, et al. The Cooperative Induction of Hypoxia-Inducible Factor-1{alpha} and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis J. Immunol., March 15, 2009; 182(6): 3510 - 3521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chiche, K. Ilc, J. Laferriere, E. Trottier, F. Dayan, N. M. Mazure, M. C. Brahimi-Horn, and J. Pouyssegur Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH Cancer Res., January 1, 2009; 69(1): 358 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-B. Shui, J. M. Arbeit, R. S. Johnson, and D. C. Beebe HIF-1: An Age-Dependent Regulator of Lens Cell Proliferation Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4961 - 4970. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Lee, Jeong Hee Moon, Eun Ah Cho, S.-E. Ryu, and Myung Kyu Lee Monoclonal Antibody-Based Screening Assay for Factor Inhibiting Hypoxia-Inducible Factor Inhibitors J Biomol Screen, July 1, 2008; 13(6): 494 - 503. [Abstract] [PDF] |
||||
![]() |
Y. A. Minamishima, J. Moslehi, N. Bardeesy, D. Cullen, R. T. Bronson, and W. G. Kaelin Jr Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure Blood, March 15, 2008; 111(6): 3236 - 3244. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-J. Hu, A. Sataur, L. Wang, H. Chen, and M. C. Simon The N-Terminal Transactivation Domain Confers Target Gene Specificity of Hypoxia-inducible Factors HIF-1{alpha} and HIF-2{alpha} Mol. Biol. Cell, November 1, 2007; 18(11): 4528 - 4542. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Semenza Hypoxia-Inducible Factor 1 (HIF-1) Pathway Sci. Signal., October 9, 2007; 2007(407): cm8 - cm8. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Groenman, M. Rutter, J. Wang, I. Caniggia, D. Tibboel, and M. Post Effect of chemical stabilizers of hypoxia-inducible factors on early lung development Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L557 - L567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Kazi and R. D. Koos Estrogen-Induced Activation of Hypoxia-Inducible Factor-1{alpha}, Vascular Endothelial Growth Factor Expression, and Edema in the Uterus Are Mediated by the Phosphatidylinositol 3-Kinase/Akt Pathway Endocrinology, May 1, 2007; 148(5): 2363 - 2374. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Friedrich, O. Janssen, and R. Hass Meeting Report: Tumor Biology--How Signaling Processes Translate to Therapy Sci. Signal., April 10, 2007; 2007(381): pe13 - pe13. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yan, S. Bartz, M. Mao, L. Li, and W. G. Kaelin Jr. The Hypoxia-Inducible Factor 2{alpha} N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo Mol. Cell. Biol., March 15, 2007; 27(6): 2092 - 2102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |